This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Piramal Enterprises Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mumbai, IN (2019)
- Maharashtra, IN (2019)
Company Filing History:
Years Active: 2019
Title: Innovations by Sangameshwar Prabhakar Sawargave
Introduction
Sangameshwar Prabhakar Sawargave is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for treating metabolic disorders.
Latest Patents
Sangameshwar holds two patents that focus on GPR120 agonists. His first patent, titled "Compounds for use as GPR120 agonists," describes a compound of formula (I) and its various forms, which are aimed at treating metabolic disorders, especially Type 2 diabetes. The second patent, "Fused heterocyclic compounds as GPR120 agonists," details a fused heterocyclic compound of Formula (I) and its applications in treating diseases mediated by the GPR120 receptor.
Career Highlights
Sangameshwar is currently employed at Piramal Enterprises Limited, where he continues to innovate in the pharmaceutical sector. His work has the potential to impact the treatment of various metabolic disorders significantly.
Collaborations
He collaborates with talented coworkers, including Sanjay Kumar and Rajiv Sharma, who contribute to his research and development efforts.
Conclusion
Sangameshwar Prabhakar Sawargave is a prominent inventor whose work in developing GPR120 agonists showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile